| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyCellularComponent | Golgi lumen | 3.78e-07 | 109 | 29 | 5 | GO:0005796 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | 1.27e-03 | 155 | 29 | 3 | GO:0098685 | |
| Domain | SEA | 5.84e-06 | 23 | 29 | 3 | PS50024 | |
| Domain | SEA_dom | 5.84e-06 | 23 | 29 | 3 | IPR000082 | |
| Domain | TIL | 1.52e-04 | 12 | 29 | 2 | PF01826 | |
| Domain | C8 | 1.52e-04 | 12 | 29 | 2 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 1.80e-04 | 13 | 29 | 2 | IPR014853 | |
| Domain | C8 | 1.80e-04 | 13 | 29 | 2 | SM00832 | |
| Domain | SEA | 2.09e-04 | 14 | 29 | 2 | SM00200 | |
| Domain | TIL_dom | 2.09e-04 | 14 | 29 | 2 | IPR002919 | |
| Domain | VWFD | 2.76e-04 | 16 | 29 | 2 | PS51233 | |
| Domain | VWD | 2.76e-04 | 16 | 29 | 2 | SM00216 | |
| Domain | VWF_type-D | 2.76e-04 | 16 | 29 | 2 | IPR001846 | |
| Domain | VWD | 2.76e-04 | 16 | 29 | 2 | PF00094 | |
| Domain | CTCK_1 | 3.51e-04 | 18 | 29 | 2 | PS01185 | |
| Domain | VWC_out | 3.92e-04 | 19 | 29 | 2 | SM00215 | |
| Domain | SEA | 5.27e-04 | 22 | 29 | 2 | PF01390 | |
| Domain | CT | 5.27e-04 | 22 | 29 | 2 | SM00041 | |
| Domain | Cys_knot_C | 6.83e-04 | 25 | 29 | 2 | IPR006207 | |
| Domain | CTCK_2 | 6.83e-04 | 25 | 29 | 2 | PS01225 | |
| Domain | VWC | 1.58e-03 | 38 | 29 | 2 | SM00214 | |
| Domain | VWFC_2 | 1.58e-03 | 38 | 29 | 2 | PS50184 | |
| Domain | VWF_dom | 1.93e-03 | 42 | 29 | 2 | IPR001007 | |
| Domain | fn3 | 1.98e-03 | 162 | 29 | 3 | PF00041 | |
| Domain | FN3 | 2.89e-03 | 185 | 29 | 3 | SM00060 | |
| Domain | FN3 | 3.55e-03 | 199 | 29 | 3 | PS50853 | |
| Domain | FN3_dom | 4.07e-03 | 209 | 29 | 3 | IPR003961 | |
| Domain | HEAT_REPEAT | 5.27e-03 | 70 | 29 | 2 | PS50077 | |
| Domain | IGv | 6.02e-03 | 75 | 29 | 2 | SM00406 | |
| Domain | ANK_REPEAT | 6.92e-03 | 253 | 29 | 3 | PS50088 | |
| Domain | ANK_REP_REGION | 7.00e-03 | 254 | 29 | 3 | PS50297 | |
| Domain | EGF_1 | 7.07e-03 | 255 | 29 | 3 | PS00022 | |
| Domain | EGF-like_CS | 7.54e-03 | 261 | 29 | 3 | IPR013032 | |
| Domain | EGF_2 | 7.86e-03 | 265 | 29 | 3 | PS01186 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 4.25e-09 | 16 | 19 | 4 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 5.55e-09 | 17 | 19 | 4 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.05e-08 | 23 | 19 | 4 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 3.46e-08 | 26 | 19 | 4 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.25e-06 | 62 | 19 | 4 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.82e-06 | 68 | 19 | 4 | M27303 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 2.72e-06 | 21 | 19 | 3 | MM15706 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 1.29e-05 | 111 | 19 | 4 | M27416 | |
| Pathway | REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS | 3.22e-05 | 140 | 19 | 4 | M27484 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 3.50e-05 | 143 | 19 | 4 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 6.77e-05 | 60 | 19 | 3 | MM15636 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 3.03e-04 | 250 | 19 | 4 | M27554 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.98e-04 | 109 | 19 | 3 | MM15164 | |
| Pathway | WP_PHYSICOCHEMICAL_FEATURES_AND_TOXICITYASSOCIATED_PATHWAYS | 3.51e-03 | 66 | 19 | 2 | M39642 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIBES_SNRNA_GENES | 4.27e-03 | 73 | 19 | 2 | MM15349 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 2.86e-12 | 18 | 30 | 5 | 18834073 | |
| Pubmed | 1.16e-08 | 6 | 30 | 3 | 19110483 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 27230679 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 26770020 | ||
| Pubmed | 1.08e-05 | 6 | 30 | 2 | 10864954 | ||
| Pubmed | 1.51e-05 | 7 | 30 | 2 | 12702769 | ||
| Pubmed | A genome-wide association study identifies protein quantitative trait loci (pQTLs). | 2.02e-05 | 61 | 30 | 3 | 18464913 | |
| Pubmed | 3.62e-05 | 218 | 30 | 4 | 19460752 | ||
| Pubmed | 3.94e-05 | 11 | 30 | 2 | 11804571 | ||
| Pubmed | NOVA2-mediated RNA regulation is required for axonal pathfinding during development. | 6.50e-05 | 14 | 30 | 2 | 27223325 | |
| Pubmed | 7.50e-05 | 15 | 30 | 2 | 20031603 | ||
| Cytoband | 7q22 | 2.86e-04 | 38 | 30 | 2 | 7q22 | |
| GeneFamily | CD molecules|Mucins | 5.30e-11 | 21 | 24 | 5 | 648 | |
| GeneFamily | Fibronectin type III domain containing | 1.20e-03 | 160 | 24 | 3 | 555 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 1.35e-02 | 134 | 24 | 2 | 861 | |
| Coexpression | NABA_ECM_AFFILIATED | 1.35e-06 | 170 | 30 | 5 | M5880 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.12e-06 | 179 | 30 | 4 | 7394e77e665bf16d3733df91bb12907be460ab44 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-06 | 181 | 30 | 4 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.40e-06 | 181 | 30 | 4 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-06 | 183 | 30 | 4 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.68e-06 | 183 | 30 | 4 | 848fc6dd129150897ee339343e83c645b6e779eb | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 7.28e-06 | 187 | 30 | 4 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | frontal_cortex-Neuronal-glutamatergic_neuron-L5_PT|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 9.89e-05 | 134 | 30 | 3 | cb676d5bbc468bd3ce1b6712d41c986ee9221ac5 | |
| ToppCell | Pericytes-IPF_04|World / lung cells shred on cell class, cell subclass, sample id | 1.38e-04 | 150 | 30 | 3 | dbc202bd6db4fb5c8b2abd1200e074a2a9e63a59 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.58e-04 | 157 | 30 | 3 | c43f2e1ea53b375a7432f17f87cfef3b2261003d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 159 | 30 | 3 | fd7db2f7328cfefdc3ada2af91006d5a91d137e1 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 159 | 30 | 3 | aaf449c768d6fbb0a1bb47746ff3bdb7f9eb8914 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 159 | 30 | 3 | 8bbdef1e927f3130b578d7d7c5ff38bbe06fab63 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-04 | 160 | 30 | 3 | 50d4f867d021abcfeb49e6812bcfd5bb57466a31 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-04 | 160 | 30 | 3 | 0f15f895f11dcabb73df79b26bfc4947f38435a7 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 160 | 30 | 3 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 160 | 30 | 3 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_ILC-NK_cell-NK_c01-FCGR3A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.67e-04 | 160 | 30 | 3 | 7d004bfe42707605b3851cb2319126acda4d4802 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c04-ANXA2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.70e-04 | 161 | 30 | 3 | 580153e131247e6ec12a1a920f050a0a763e7e87 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c09-GZMK-FOS_l|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.76e-04 | 163 | 30 | 3 | e4077e587895c85bc806be05ff5d451088e39468 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 165 | 30 | 3 | e2aebb2fe197151e019371b8960f76f0c2386f08 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 165 | 30 | 3 | b087771499aeb31cc4a338d2d0a9392a4ec1ac45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical-aged|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.83e-04 | 165 | 30 | 3 | d8f8b088fd28a6b9dbd6b51bcaee42000e963321 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-04 | 166 | 30 | 3 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-04 | 166 | 30 | 3 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.86e-04 | 166 | 30 | 3 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.86e-04 | 166 | 30 | 3 | 94636dbc039f794c735960c3425e00bdd5523602 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-04 | 168 | 30 | 3 | fc80e4fecfc92458eb627013a983041d8ca025a9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-04 | 168 | 30 | 3 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-04 | 168 | 30 | 3 | 315ca578c945aeeb77acda2727f3e6db8b43f43e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.07e-04 | 172 | 30 | 3 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.14e-04 | 174 | 30 | 3 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.17e-04 | 175 | 30 | 3 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.17e-04 | 175 | 30 | 3 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | wk_20-22-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.21e-04 | 176 | 30 | 3 | 52af8f717dbd3b59eeb868b8b7b256a8f3e57d7a | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-04 | 176 | 30 | 3 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.21e-04 | 176 | 30 | 3 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 2.21e-04 | 176 | 30 | 3 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.25e-04 | 177 | 30 | 3 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.29e-04 | 178 | 30 | 3 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | (5)_Glands_mucous|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 2.29e-04 | 178 | 30 | 3 | f0f19b0d78f2cc5df4d4c321a953a6e447d5114a | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.32e-04 | 179 | 30 | 3 | 859cd8ee414ad6207c046ada2e655e49322dd01c | |
| ToppCell | wk_15-18-Endothelial-Blood_vessel_endothelial-OMD+_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.32e-04 | 179 | 30 | 3 | 8c9ed247e1c4d655b81ce2f24a9936a7cade718a | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.36e-04 | 180 | 30 | 3 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.36e-04 | 180 | 30 | 3 | 3dc80bc636bf0e6ffc9762853132a9fe59fd1f66 | |
| ToppCell | nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.36e-04 | 180 | 30 | 3 | 668a2d8e1d5a390309d5eb62c836f5903144bea9 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.44e-04 | 182 | 30 | 3 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 2.48e-04 | 183 | 30 | 3 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 2.48e-04 | 183 | 30 | 3 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-04 | 183 | 30 | 3 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.48e-04 | 183 | 30 | 3 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.48e-04 | 183 | 30 | 3 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 2.52e-04 | 184 | 30 | 3 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.56e-04 | 185 | 30 | 3 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.60e-04 | 186 | 30 | 3 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.64e-04 | 187 | 30 | 3 | ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.72e-04 | 189 | 30 | 3 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 2.77e-04 | 190 | 30 | 3 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.77e-04 | 190 | 30 | 3 | f6c38d197fd9d69a4f97cb2e72cd4747984c1a86 | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 2.85e-04 | 192 | 30 | 3 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | Mesenchymal_cells-Ng2+_MSCs|World / Lineage and Cell class | 2.85e-04 | 192 | 30 | 3 | 0703b8ec6960ff975ee5a2737054db67cab016b5 | |
| ToppCell | IPF-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 2.85e-04 | 192 | 30 | 3 | e911e286da26202853f9650ba3cdefe5a5c9b585 | |
| ToppCell | Control-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 2.90e-04 | 193 | 30 | 3 | 5896242f713ae5fd1a4ebb63827f15d7279dced2 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 2.90e-04 | 193 | 30 | 3 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.99e-04 | 195 | 30 | 3 | e7230a849ea31e6eef9bc6f5468938499450582d | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.99e-04 | 195 | 30 | 3 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.99e-04 | 195 | 30 | 3 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 3.03e-04 | 196 | 30 | 3 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.03e-04 | 196 | 30 | 3 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Bronchus_Control_(B.)|World / Sample group, Lineage and Cell type | 3.08e-04 | 197 | 30 | 3 | b6dff2ee108813e18657e2d8cf850e2423f8c8e9 | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 3.08e-04 | 197 | 30 | 3 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.08e-04 | 197 | 30 | 3 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.12e-04 | 198 | 30 | 3 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 3.17e-04 | 199 | 30 | 3 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | 5'-Adult|5' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.17e-04 | 199 | 30 | 3 | 8b7b1fcea9a06522fdfab85d0dfd33010ae96d75 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.22e-04 | 200 | 30 | 3 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| Computational | Genes in the cancer module 51. | 7.05e-04 | 36 | 12 | 2 | MODULE_51 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.36e-03 | 50 | 12 | 2 | GAVISH_3CA_MALIGNANT_METAPROGRAM_27_OLIGO_PROGENITOR | |
| Computational | Genes in the cancer module 237. | 1.82e-03 | 58 | 12 | 2 | MODULE_237 | |
| Disease | cholangiocarcinoma (is_marker_for) | 3.79e-05 | 64 | 30 | 3 | DOID:4947 (is_marker_for) | |
| Disease | bacteriemia | 1.35e-04 | 17 | 30 | 2 | EFO_0003033 | |
| Disease | Sjogren's syndrome (is_marker_for) | 2.72e-04 | 24 | 30 | 2 | DOID:12894 (is_marker_for) | |
| Disease | S-6-hydroxywarfarin measurement | 5.05e-04 | 368 | 30 | 4 | EFO_0803326 | |
| Disease | unipolar depression, information processing speed, cognitive function measurement | 1.05e-03 | 47 | 30 | 2 | EFO_0003761, EFO_0004363, EFO_0008354 | |
| Disease | tuberculosis | 1.36e-03 | 216 | 30 | 3 | MONDO_0018076 | |
| Disease | Acute Cerebrovascular Accidents | 1.38e-03 | 54 | 30 | 2 | C0751956 | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 1.76e-03 | 61 | 30 | 2 | DOID:3587 (is_marker_for) | |
| Disease | response to opioid | 1.76e-03 | 61 | 30 | 2 | EFO_0008541 | |
| Disease | Cerebrovascular accident | 1.82e-03 | 62 | 30 | 2 | C0038454 | |
| Disease | erosive tooth wear measurement | 3.79e-03 | 90 | 30 | 2 | EFO_0009331 | |
| Disease | Parkinson disease | 4.17e-03 | 321 | 30 | 3 | MONDO_0005180 | |
| Disease | Ischemic stroke | 4.28e-03 | 324 | 30 | 3 | HP_0002140 | |
| Disease | blood cobalt measurement | 4.74e-03 | 101 | 30 | 2 | EFO_0007577 | |
| Disease | unipolar depression | 6.88e-03 | 1206 | 30 | 5 | EFO_0003761 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GSSTWTSSGIPFSFV | 476 | P23470 | |
| RTAWTSATSGILGTT | 2211 | Q9HC84 | |
| TVRTAWTSATSGTLG | 2766 | Q9HC84 | |
| SESVSKGAFSTTWST | 256 | Q68CQ1 | |
| SVSSSVTSGLTGWAA | 281 | Q96CB8 | |
| FSSSTWVTLSDGTGR | 121 | Q96RS6 | |
| TGGSRGTKTDTWSTT | 331 | Q0D2K2 | |
| TTTFWSGTHSTASPG | 8516 | Q8WXI7 | |
| TTGSSTERGSVYSWR | 256 | A5PLN7 | |
| TTSSASWVAGSFSPV | 1101 | Q9P2D0 | |
| HKSGRSLWTTSSGSS | 506 | Q8IYT1 | |
| LSLSTSSSSGWTAVG | 771 | Q2LD37 | |
| ITSGWSSSGTSTGAS | 2016 | Q7Z5P9 | |
| TTTETTSHRWGTTET | 2166 | Q02505 | |
| RVSSTWTTTTSATGL | 436 | Q14432 | |
| VEQRSSVTSSWTSGA | 126 | Q7L5A3 | |
| GVSSSFSSSSWKRVS | 381 | Q6AI08 | |
| KSTSTTGGLTSVSWS | 61 | O95297 | |
| AGSSSGFHSWTRTSV | 41 | P12036 | |
| GFHSWTRTSVSSVSA | 46 | P12036 | |
| TGLTWRSGTASSVSY | 671 | Q9H461 | |
| FSTTVTGRTCQSWSS | 1286 | P08519 | |
| GTFSTTVTGRTCQSW | 1626 | P08519 | |
| SWGRQSTASSFVDSS | 361 | A6NKL6 | |
| SGTTAWRAASAVGAT | 261 | A6NJG2 | |
| STSGLRWSSGSTFTA | 76 | Q6ZU45 | |
| TWSSITSTAFTTGGR | 1116 | Q92752 | |
| SSTTAGWSGSSSGQT | 446 | Q8IYB5 | |
| STSAWSSSFSLDTVG | 2821 | Q709C8 | |
| LTVGSYNSTSISVSW | 746 | Q9HCK4 | |
| FTTAGSRSNGTWLSA | 341 | Q5H9I0 | |
| TTWTLSTSSVSSQGS | 456 | Q8TEC5 | |
| VRWSSTSSSGSSSGS | 516 | Q5SXM2 | |
| GSTTRQGESTTFHSW | 766 | Q9UKN1 | |
| GSTTRQGESTTFQSW | 1821 | Q9UKN1 | |
| GSTTRQGESTTFQSW | 4461 | Q9UKN1 | |
| WGSRSSTTSTATTQM | 336 | Q8IZF0 |